Colorectal cancer incidence is increasing among young adults
the ONA take:
Screening efforts have resulted in an overall decrease in incidence of colorectal cancer (CRC). However, incidence of the disease in young adults (ages 20-39 years) has increased in the past 20 to 30 years.
Little is known about CRC incidence in young adults because recommended screening for people of average risk person begins at age 50 years. Researchers at the University of California, Irvine, analyzed 231,544 CRC cases from 1988-2009 from the California Cancer Registry to identify high-risk subgroups.
Their study cases included 5,617 young adults ages 20-39 years. Although the absolute incidence of CRC per 100,000 in this group was low, the researchers found CRC incidence increasing over time among both males and females, particularly for distal colon cancer in Hispanic females ages 20-29 years.
The researchers conclude that absolute incidence of CRC is significantly lower in among the young adult populations; however, incidence is increasing among young adults compared with the older screened population. They also note a need for further research to better characterize young adults at increased risk for CRC.
Incidence of colorectal cancer in young adults has increased in the past 20 to 30 years.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|